Promoting Effects of Ganoderma lucidum Polysaccharides on B16F10 Cells to Activate Lymphocytes

Basic and Clinical Pharmacology and Toxicology

Volumn 108, Issue 3, 2011, Pages 149-154

  Sun, Li Xin ^a,b   Lin, Zhi Bin ^a   Li, Xue Jun ^a   Li, Min ^a   Lu, Jie ^b   Duan, Xin Suo ^b   Ge, Zhi Hua ^b   Song, You Xin ^b   Xing, En Hong ^b   Li, Wei Dong ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b CHENGDE MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD69 ANTIGEN; FAS LIGAND; GAMMA INTERFERON; GANODERMA LUCIDUM EXTRACT; GANODERMA LUCIDUM POLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER IMMUNOTHERAPY; CYTOKINE PRODUCTION; DRUG ACTIVITY; FEMALE; GANODERMA LUCIDUM; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; DRUGS, CHINESE HERBAL; FAS LIGAND PROTEIN; FEMALE; H-2 ANTIGENS; INTERFERON-GAMMA; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; POLYSACCHARIDES; REISHI; SPLEEN;

GANODERMA LUCIDUM;

EID: 79951727773     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2010.00632.x     Document Type: Article

References (26)

1. Old LJ, Boyse EA. Immunology of experimental tumors. Annu Rev Med 1964;15:167-86.
2. Ochsenbein AF. Principles of tumor immunosurveillance and implications for immunotherapy. Cancer Gene Ther 2002;9:1043-55.
3. Shao BM, Dai H, Xu W, Lin ZB, Gao XM. Immune receptors for polysaccharides from Ganoderma lucidum. Biochem Biophys Res Commun 2004;323:133-41.
4. Lin ZB, Zhang HN. Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms. Acta Pharmacol Sin 2004;25:1387-95.
5. Zhu XL, Lin ZB. Effect of Ganoderma lucidum polysaccharides on cytokine-induced killer cells proliferation and cytotoxicity. Acta Pharmacol Sin 2005;26:1130-7.
6. Zhu XL, Lin ZB. Modulation of cytokines production, granzyme B and perforin in murine CIK cells by Ganoderma lucidum polysaccharides. Carbohydr Polym 2006;63:188-97.
7. Cao LZ, Lin ZB. Regulation on maturation and function of dendritic cells by Ganoderma lucidum polysaccharides. Immunol Lett 2002;83:163-9.
8. Cao LZ, Lin ZB. Regulatory effect of Ganoderma lucidum polysaccharides on cytotoxic T-lymphocytes induced by dendritic cells in vitro. Acta Pharmacol Sin 2003;24:312-26.
9. Cao QZ, Lin ZB. Ganoderma lucidum polysaccharides peptide inhibits the growth of vascular endothelial cell and the induction of VEGF in human lung cancer cell. Life Sci 2006;78:1457-63.
10. Zhu XL, Chen AF, Lin ZB. Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice. J Ethnopharmacol 2007;111:219-26.
11. Li WD, Zhang BD, Wei R, Liu JH, Lin ZB. Reversal effect of Ganoderma lucidum polysaccharide on multidrug resistance in K562/ADM cell line. Acta Pharmacol Sin 2008;29:620-7.
12. Ikekawa T, Ikeda Y, Fukuoka F. Antitumor activity of polysaccharides from Serratia marcescens. Gann 1975;66:317-8.
13. Gao Y, Zhou S, Jiang W, Huang M, Dai X. Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol Invest 2003;32:201-15.
14. Gao Y, Gao H, Chan E, Tang W, Xu A, Yang H et al. Antitumor activity and underlying mechanisms of ganopoly, the refined polysaccharides extracted from Ganoderma lucidum, in mice. Immunol Invest 2005;34:171-98.
15. Chen HS, Tsai YF, Lin S, Lin CC, Khoo KH, Lin CH et al. Studies on the immuno-modulating and anti-tumor activities of Ganoderma lucidum (Reishi) polysaccharides. Bioorg Med Chem 2004;12:5595-601.
16. Vance BA, Harley PH, Backlund PS, Ward Y, Phelps TL, Gress RE. Human CD69 associates with an N-terminal fragment of calreticulin at the cell surface. Arch Biochem Biophys 2005;438:11-20.
17. Cebria'n M, Yague E, Rincon M, Lopez-Botet M, de Landazuri MO, Sanchez-Madrid F. Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes. J Exp Med 1988;168:1621-37.
18. Testi R, Phillips JH, Lanier L. T cell activation via Leu-23 (CD69). J Immunol 1989;143:1123-8.
19. Lewkowich IP, Rempel JD, HayGlass KT. Prevention of allergen-specific, Th2-biased immune responses in vivo: role of increased IL-12 and IL-18 responsiveness. J Immunol 2005;175:4956-62.
20. de Vries JF, von dem Borne PA, van Luxemburg-Heijs SA, Heemskerk MH, Willemze R, Falkenburg JH et al. Differential activation of the death receptor pathway in human target cells induced by cytotoxic T lymphocytes showing different kinetics of killing. Haematologica 2007;92:1671-8.
21. Farrar MA, Schreiber RD. The molecular cell biology of interferon-γ and its receptor. Annu Rev Immunol 1993;11:571-611.
22. Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-γ. Annu Rev Immunol 1997;15:749-95.
23. Kaplan DH, Shankaran V, Dighe AS, Stockert E, Aguet M, Old LJ et al. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci U S A 1998;95:7556-61.
24. Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ et al. IFN gamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 2001;410:1107-11.
25. Frauwirth KA, Thompson CB. Activation and inhibition of lymphocytes by costimulation. J Clin Invest 2002;109:295-9.
26. Nurieva R, Thomas S, Nguyen T, Martin-Orozco N, Wang Y, Kaja MK et al. T-cell tolerance or function is determined by combinatorial costimulatory signals. EMBO J 2006;25:2623-33.